Categories
Archives
Receive Email Updates
-
-
-
Certified Licensing Professionals, Inc., 2021 
Disclaimer
This blog, Patents4Life, does not contain legal advice and is for informational purposes only. Its publication does not create an attorney-client relationship nor is it a solicitation for business. This is the personal blog of Warren Woessner and does not reflect the views of Schwegman Lundberg & Woessner, or any of its attorneys or staff. To the best of his ability, the Author provides current and accurate information at the time of each post, however, readers should check for current information and accuracy.
-
- About Me
Warren D. Woessner
Pages
Archives
Tag Archives: Myriad
Fed. Cir. Orders Briefing in Myriad Remand
On April 30th, in response to the Supreme Court’s GVR of the Myriad appeal (AMP et al. are still trying to get the claims to isolated DNA molecules and the use of a transgenic cell comprising the BRCA1 gene to … Continue reading
Posted in Patent Eligible Subject Matter
Tagged Federal Circuit, Mayo, Myriad, Patent Law, Supreme Court, Warren Woessner
1 Comment
Supreme Court Remands In Myriad Appeal
Today, as predicted by many commentators, the Supreme Court set aside the ruling by the Fed. Cir. that claims to isolated DNA sequences that are the BRCA 1 or 2 gene, or fragments thereof, are patentable subject matter. The Supreme … Continue reading
Myriad Revisited – The Consequences of Prometheus Unbound
In my last post on Prometheus, I concluded: It is hard to think of a diagnostic assay claim that does not either detect the +/- presence of a marker (like anti-HIV antibodies) or involve the comparison of the level of … Continue reading
Top 2011 IP Stories on Patents4Life
I spent a day or two looking back over the breaking IP news that resulted in posts on Patents4Life. I wrote most of them, but want to take a pause to thank regular contributors Paul Cole, Ron Schutz and Stefan … Continue reading
Posted in Miscellaneous
Tagged AIA, America Invents Act, AMP, ANDA, Bayh-Dole Act, biotechnology, biotechnology law, biotechnology news, caraco, court of appeals, Dr. Stefan Danner, European patent, Federal Circuit, intellectual property, ip, microsoft v i4i, Myriad, Patent Law, patents, Paul Cole, Pharmaceutical law, Prometheus v. Mayo, saint-gobain, Schutz, sherley, Stanford v Roche, Supreme Court, Therasense, USPTO, Warren Woessner, WDR
Leave a comment